Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hervé Le Louët"'
Publikováno v:
Frontiers in Drug Safety and Regulation, Vol 3 (2023)
In the field of drug safety, causality assessment aims to determine the level of plausibility of the relationship between an adverse event and exposure to a particular product. It is after the causality assessment process that we will be able to poin
Externí odkaz:
https://doaj.org/article/87bcfc33067f4f06bea99b13aaae2a46
Autor:
Hervé Le Louët, Peter J. Pitts
Publikováno v:
Therapeutic Innovation & Regulatory Science. 57:100-103
Publikováno v:
Therapies. 76:715-723
Summary Background and aim The occurrence of drug induced liver injury (DILI) is the most common reason of post-marketing withdrawals. DILI in humans is difficult to predict using in vitro cytotoxicity screening and animal studies. A review of hepato
Publikováno v:
Journal of Commercial Biotechnology. 26
Around the world, scientists, manufacturers and governments jumped into the race to develop a vaccine to combat COVID-19 and its associated lockdowns. A global response was required since defeating the pandemic requires global alignment. The availabi
Publikováno v:
Drug safety. 43(2)
The use of immune checkpoint inhibitors (ICI) in melanoma and non-small cell lung cancer patients is associated with the onset of vitiligo. However, previous studies have suggested conflicting results on the conditions of occurrence of ICI-induced vi
Autor:
Andra Economu-Dubosc, Fatiha Medkour, Valérie Farrenq, Pascal Claudepierre, Sylvie Bastuji-Garin, Xavier Chevalier, Hervé Le Louët, Florence Canoui-Poitrine, Jacques-Eric Gottenberg, Laure Thomas
Publikováno v:
The Journal of Rheumatology. 39:893-898
Objective.Psoriasis could be a paradoxical reaction to tumor necrosis factor-α antagonist therapy and it has been reported with rituximab therapy. Our objective was to assess the rates of new-onset and flare of preexisting psoriasis in patients taki
Publikováno v:
Therapies. 65:255-259
Background Since donepezil and memantine are currently used for treating Alzheimer’s disease, it is interesting to analyse, reassess and compare their safety profile in order to promote a better use. Methods All spontaneous reports of suspected ser
Autor:
Samy Babai, Daphney Nasrallah-Irles, Laure Thomas, Anne Castot, Hervé Le-Louët, Bernard Delorme
Publikováno v:
Therapies. 63:385-392
Resume Introduction L’evolution des systemes de vigilance des produits de sante tend a une implication croissante des patients. C’est pourquoi, le signalement, par le patient lui-meme, de son effet indesirable medicamenteux doit etre envisage. Ma
Autor:
Hervé Le Louët, Elisabeth Loupi, Françoise Haramburu, Atika Abelin, Didier Guillemot, Alexis Jacquet, Carmen Kreft-Jais, Odile Launay, Muriel Malbezin
Publikováno v:
Therapies. 62:241-244
Le vaccin est un medicament biologique (le plus souvent anti-infectieux) administre dans un but le plus souvent preventif, dont l'effet n'est pas pharmacologique mais immunologique. Il doit etre evalue par les techniques habituelles de la pharmacolog
Autor:
J.-C. Roujeau, Martin Schumacher, C Lonjou, Nicolas Borot, Hervé Le-Louët, Maja Mockenhaupt, Alain Hovnanian, L Thomas, N Ledger, Erika Graf, C de Toma
Publikováno v:
The Pharmacogenomics Journal. 6:265-268
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe cutaneous adverse drug reactions, which can be caused by a certain number of specific drugs among which is carbamazepine, an antiepileptic agent. A very strong as